• Facebook
  • X
  • Events
  • News
  • Donate
Search
Hit enter to search or ESC to close
New Jersey Alliance for Clinical and Translational Science New Jersey Alliance for Clinical and Translational Science
  • Home
  • About
    • Mission
    • Membership
    • Affiliated Institutions
    • NJ ACTS Leadership
    • Cite the CTSA and Publications
    • CTSA Resources
    • Elements
  • Community
    • Our Services
    • Community Leadership
    • Volunteering for a Clinical Trial FAQs
    • Find a Clinical Trial
    • Partnership & Innovation Funding Opportunities
    • COVID-19 Resources
  • Investigator Resources
    • Funding Opportunities
    • Biostatistics, Epidemiology, Research Design (BERD)
    • Informatics Services
    • Regulatory Knowledge & Support
    • Special Populations in Research
    • Team Science
    • Genetically informed Research, Education, And Treatment
    • Biomarkers
    • ResearchMatch (RM)
    • Dissemination & Implementation Workgroup
    • COVID-19
    • Additional Resources
  • Education & Training
    • Workforce Development
    • R25 Clinical Research Experiential Summer Training (CREST)
    • Badges
    • Seminars, Workshops, Media Library
    • Learning Health System – STAR
    • Promoting STEM in High School and Earlier
    • Undergraduate Education and Training
    • Beyond Traditional Graduate Courses
    • NJ ACTS Collaborative Graduate Programs
  • K12 & T32
    • K12 Mentored Career Development Awards
    • T32 Predoctoral Training Awards
  • Clinical Trials Office
    • About
    • OnCore
    • Solutions
    • Services
    • I want to start a clinical trial
    • Resources
  • Contact Us
    • NJ ACTS Newsletter
Select Page

New Jersey health officials are recruiting children under 5 for COVID bivalent vaccine trials.

by William Jester | Dec 7, 2022 | Community, Covid, News

Local vaccine trial sites are recruiting young children to test COVID-19 bivalent doses more than two months after the vaccines were authorized for use in adults, teens, and older children. Scientists will study the safety and efficacy of Pfizer-BioNTech’s bivalent...

Your Sleep Aids May Be Key to Treating More Than Insomnia, Study Finds.

by William Jester | Dec 6, 2022 | Community, News

A new Rutgers study suggests that sleep aids may do more than mitigate insomnia: They might also help reduce cravings for those struggling with alcohol and drug addiction. Why? It comes down to a hormone called orexin that stimulates drug and alcohol cravings, more...

Psychologists Offer Advice to Help Children Understand Alzheimer’s During the Holidays.

by William Jester | Dec 6, 2022 | Community, News

Holidays can be especially challenging for the six million Americans with Alzheimer’s disease and the families who love and care for them. Young children may have difficulty reconciling the season’s joy with the confusion, fear, or sadness that surface when a...

Full-dose Blood Thinners Could Prevent COVID-Related Clotting in Hospitalized Patients

by William Jester | Dec 5, 2022 | Community, Covid, News

Anyone who has had COVID-19—even if it was a mild case—is at a higher risk of developing blood clots for months after recovery. If untreated, blood clot complications such as deep vein thrombosis and pulmonary embolism can cause serious damage to the heart or lungs. A...

Register Now for the New Clinical Research Coordination Badge!

by Pamela Dahlen | Dec 2, 2022 | Community, News

Interested in an Entry-level Position as a Study Coordinator?​  The Rutgers Biomedical Health Sciences (RBHS) in collaboration with the New Jersey Alliance for Clinical and Translational Sciences (NJ ACTS) developed a 6-week academic badge especially designed for...
« Older Entries
Next Entries »

Recent Posts

  • Mentoring Biomedical Graduate Students and Postdocs – Workshop 10/9
  • NJ ACS Community Event on 10/13 from 10:30 – 12:00
  • NJ ACTS Special Populations Seminar 9/29 – Register Now
  • NIH Fellowship Writing Group: Call for Applications – Sign Up by 8/25
  • Join The National Clinical Cohort Collaborative (N3C) Community Forum on 7/30

Archives

  • 2026
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2025
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2024
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2023
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2022
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2021
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2020
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2019
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2018
    • December

Categories

  • Community (2,501)
  • Covid (1,001)
  • CTO Events (6)
  • News (3,177)
  • Pilots (21)
Rutgers R Block logo graphic

THIS SITE

About

Membership

Community

Investigator Resources

Education & Training

News

Events

Contact

CONTACT US

New Jersey Alliance For Clinical and Translational Science (NJ ACTS)

 


  • Facebook

  • Twitter

  • YouTube

  • LinkedIn

© 2019, New Jersey Alliance for Clinical and Translational Science (NJ ACTS). All rights reserved.| Privacy Policy

Rutgers, The State University of New Jersey, is an equal access/equal opportunity institution. Individuals with disabilities are encouraged to direct suggestions, comments, or complaints concerning any accessibility issues with Rutgers web sites to accessibility@rutgers.edu or complete the Report Accessibility Barrier or Provide Feedback Form.